Status | Study |
Available |
Study Name: Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation Condition: Limbal Stem Cell Deficiency Stevens-johnson Syndrome Ocula Date: 2014-05-14 Interventions: Biological: cultivated oral mucosal epithelial sheet transplantation Autologous cultivated oral mucosal |
Withdrawn |
Study Name: Topical Infliximab in Autoimmune Eyes With Keratoprosthesis Condition: Stevens-Johnson Syndrome Toxic Epidermal Necrolysis (Lyell) Syndrome Date: 2014-04-27 Interventions: Drug: topical infliximab topical infliximab administered QID for 3 months followed by BID for 9 months |
Terminated |
Study Name: Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis Condition: Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Date: 2014-01-13 Interventions: Drug: Palifermin Other Name: Kepivance |
Completed |
Study Name: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% Condition: Plaque Psoriasis Date: 2013-06-26 Interventions: Drug: Clobex Spray Other Name: Clobetasol propionate spray |
Completed |
Study Name: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. Condition: Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Date: 2012-09-20 Interventions: Drug: Intravenous immunoglobulin |
Recruiting |
Study Name: Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis Condition: Chemical Injuries Unspecified Complication of Corneal Transplant Date: 2012-04-10 Interventions: Drug: Riboflavin Used to treat donor cornea before implantation |
Withdrawn |
Study Name: Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) Condition: Stevens-Johnson Syndrome Corneal Blindness Date: 2010-11-19 Interventions: Drug: Infliximab The drug will be administered intravenously every month for 110 weeks (duration of the |
Completed |
Study Name: Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye Condition: Stevens-Johnson Syndrome Date: 2010-11-08 Interventions: Drug: 0.05%cyclosporin eye drop use twice daily for 6 months |
Completed |
Study Name: Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye Condition: Stevens-Johnson Syndrome Date: 2010-05-01 |
Completed |
Study Name: Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome. Condition: Symblepharon Dry Eye Ocular Surface Disease Date: 2010-01-19 Interventions: Procedure: Salivary Gland and Labial Mucous Membrane Transplantation Minor salivary glands (SG) will be |